Abstract
Ulcerative colitis (UC) patients frequently require iron supplementation to remedy anemia. The impact of systemic iron supplementation (intraperitoneal injection) on UC-associated carcinogenesis was assessed in mice subjected to cyclic dextran sulfate sodium (DSS) treatment and compared with dietary iron enrichment. Systemic iron supplementation, but not a twofold iron diet, remedied iron deficiency as indicated by the histochemical detection of splenic iron stores. A twofold iron diet, but not systemic iron, increased iron accumulation in colonic luminal contents, at the colonic mucosal surface, and in superficial epithelial cells. Colitis-associated colorectal tumor incidence after 15 DSS cycles was not affected by systemic iron (2/28; 7.1%) compared to nonsupplemented controls (4/28; 14.1%) but was significantly increased by the twofold iron diet (24/33; 72.7%) (P < 0.001). Mechanistic study revealed that systemic iron had no effect on DSS-induced inflammation, or colonic iNOS and COX-2 protein levels, compared to controls. Systemic iron supplementation for 16 weeks replenished splenic iron in a spontaneous colitis model (interleukin-2-deficient mice) and significantly reduced colonic inflammation compared to interleukin-2 (−/−) controls without increasing hyperplastic lesions. These results suggest that iron supplemented systemically could be used to remedy anemia in UC patients without exacerbating inflammation or enhancing colon cancer risk. These findings need to be verified in clinical studies.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182–205, 1998
Farrell RJ, Peppercorn MA: Ulcerative colitis. Lancet 359:331–340, 2002
Wilson A, Reyes E, Ofman J: Prevalence and outcomes of anemia in inflammatory bowel disease: a systematic review of the literature. Am J Med 116(Suppl 7A):44S–49S, 2004
Truelove SC: Medical management of ulcerative colitis. Br Med J 2:605–607, 1968
Barrison IG, Roberts PD, Kane SP: Oral or parenteral iron treatment in chronic ulcerative colitis? Br Med J (Clin Res Ed) 282: 1514, 1981
Pietrangelo A: Physiology of iron transport and the hemochromatosis gene. Am J Physiol Gastrointest Liver Physiol 282:G403–G414, 2002
Knutson M, Wessling-Resnick M: Iron metabolism in the reticuloendothelial system. Crit Rev Biochem Mol Biol 38:61–88, 2003
Burns DL, Mascioli EA, Bistrian BR: Parenteral iron dextran therapy: a review. Nutrition 11:163–168, 1995
Reifen R, Matas Z, Zeidel L, Berkovitch Z, Bujanover Y: Iron supplementation may aggravate inflammatory status of colitis in a rat model. Dig Dis Sci 45:394–397, 2000
Carrier J, Aghdassi E, Platt I, Cullen J, Allard JP: Effect of oral iron supplementation on oxidative stress and colonic inflammation in rats with induced colitis. Aliment Pharmacol Ther 15:1989–1999, 2001
Seril DN, Liao J, Ho KL, Warsi A, Yang CS, Yang GY: Dietary iron supplementation enhances DSS-induced colitis and associated colorectal carcinoma development in mice. Dig Dis Sci 47:1266–1278, 2002
Grisham MB: Oxidants and free radicals in inflammatory bowel disease. Lancet 344:859–861, 1994
Morris CJ, Earl JR, Trenam CW, Blake DR: Reactive oxygen species and iron—A dangerous partnership in inflammation. Int J Biochem Cell Biol, 27:109–122, 1995
Babbs CF: Oxygen radicals in ulcerative colitis. Free Radical Biol Med 13:169–181, 1992
Lashner BA, Silverstein MD, Hanauer SB: Hazard rates for dysplasia and cancer in ulcerative colitis. Results from a surveillance program. Dig Dis Sci 34:1536–1541, 1989
Sugita A, Sachar DB, Bodian C, Ribeiro MB, Aufses JAH, Greenstein AJ: Colorectal cancer in ulcerative colitis. Influence of anatomical extent and age at onset on colitis-cancer interval. Gut 32:167–169, 1990
Lashner BS, Provencher KS, Bozdech, JM, Brzezinski A: Worsening risk for the development of dysplasia or cancer in patients with chronic ulcerative colitis. American Journal of Gastroenterology 90:377–380, 1995
Fitzpatrick FA: Inflammation, carcinogenesis and cancer. International Immunopharmacology 1:1651–1667, 2001
Seril DN, Liao J, Yang G-Y, Yang CS: Oxidative stress and ulcerative colitis-associated carcinogenesis: studies in humans and animal models. Carcinogenesis 24:353–362, 2003
Agoff SN, Brentnall TA, Crispin DA, Taylor SL, Raaka S, Haggitt RC, Reed MW, Afonina IA, Rabinovitch PS, Stevens AC, Feng Z, Bronner MP: The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia. Am J Pathol 157:737–745, 2000
Jaiswal M. LaRusso NF, Gores GJ: Nitric oxide in gastrointestinal epithelial cell carcinogenesis: linking inflammation to oncogenesis. Am J Physiol Gastrointest Liver Physiol 281:G626–G634, 2001
Stevens RG, Graubard BI, Micozzi MS, Neriishi K, Blumberg BS: Moderate elevation of body iron level and increased risk of cancer occurrence and death. Int J Cancer 56:364–369, 1994
Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I: Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75:253–261, 1993
Okayasu I, Hatakeyama S, Yamada M, Ohkusa T, Inagaki Y, Nakaya R: A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98:694–702, 1990
Mahler M, Bristol IJ, Leiter EH, Workman AE, Birkenmeier EH, Elson CO, Sundberg JP: Differential susceptibility of inbred mouse strains to dextran sulfate sodium-induced colitis. Am J Physiol 274:G544–G451, 1998
Weiss G: Iron and anemia of chronic disease. Kidney Int Suppl 69:S12–S17, 1999
Burns DL, Pomposelli JJ: Toxicity of parenteral iron dextran therapy. Kidney Int Suppl 69:119–124, 1999
Aghdassi E, Carrier J, Cullen J, Tischler M, Allard JP: Effect of iron supplementation on oxidative stress and intestinal inflammation in rats with acute colitis. Dig Dis Sci 46:1088–1094, 2001
Herbert V, Shaw S, Jayatilleke E, Stopler-Kasdan T: Most free-radical injury is iron-related: it is promoted by iron, hemin, holoferritin and vitamin C, and inhibited by desferoxamine and apoferritin. Stem Cells 12:289–303, 1994
Grisham MB, Granger DN: Neutrophil-mediated mucosal injury: role of reactive oxygen metabolites. Dig Dis Sci 33:6S–15S, 1988
Sesink AL, Termont DS, Kleibeuker JH, Van der Meer R: Red meat and colon cancer: the cytotoxic and hyperproliferative effects of dietary heme. Cancer Res 59:5704–5709, 1999
Stevens RG, Jones DY, Micozzi MS, Taylor PR: Body iron stores and the risk of cancer. N Engl J Med 319:1047–1052, 1988
Author information
Authors and Affiliations
Corresponding author
Additional information
This work was supported by Research Project Grant RPG-00-034-01-CNE from the American Cancer Society and NIH Grant RO1CA104741-01A1 (G.-Y.Y.).
Rights and permissions
About this article
Cite this article
Seril, D.N., Liao, J., Yang, C.S. et al. Systemic Iron Supplementation Replenishes Iron Stores Without Enhancing Colon Carcinogenesis in Murine Models of Ulcerative Colitis: Comparison with Iron-Enriched Diet. Dig Dis Sci 50, 696–707 (2005). https://doi.org/10.1007/s10620-005-2560-6
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/s10620-005-2560-6